Cargando…
A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin
BACKGROUND: This study used data from different sources to identify the extent of the unmet need for postprandial glycemic control in patients with type 2 diabetes mellitus (T2DM) after the initiation of basal insulin therapy in Europe, Asia Pacific, the United States, and Latin America. METHODS: Di...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347910/ https://www.ncbi.nlm.nih.gov/pubmed/27606888 http://dx.doi.org/10.1002/dmrr.2858 |
_version_ | 1782514137536921600 |
---|---|
author | Raccah, Denis Chou, Engels Colagiuri, Stephen Gaàl, Zsolt Lavalle, Fernando Mkrtumyan, Ashot Nikonova, Elena Tentolouris, Nikolaos Vidal, Josep Davies, Melanie |
author_facet | Raccah, Denis Chou, Engels Colagiuri, Stephen Gaàl, Zsolt Lavalle, Fernando Mkrtumyan, Ashot Nikonova, Elena Tentolouris, Nikolaos Vidal, Josep Davies, Melanie |
author_sort | Raccah, Denis |
collection | PubMed |
description | BACKGROUND: This study used data from different sources to identify the extent of the unmet need for postprandial glycemic control in patients with type 2 diabetes mellitus (T2DM) after the initiation of basal insulin therapy in Europe, Asia Pacific, the United States, and Latin America. METHODS: Different levels of evidence were used as available for each country/region, with data extracted from seven randomized controlled trials (RCTs), three clinical trial registries (CTRs), and three electronic medical record (EMR) databases. Glycemic status was categorized as “well controlled” (glycated hemoglobin [HbA(1c)] at target [<7%]), “residual hyperglycemia” (fasting plasma glucose [FPG] but not HbA(1c) at target [FPG <7.2/7.8 mmol/L, <130/140 mg/dL, depending on country‐specific recommendations]), or “uncontrolled” (both FPG and HbA(1c) above target). Predictor factors were identified from the RCT data set using logistic regression analysis. RESULTS: RCT data showed that 16.9% to 28.0%, 42.7% to 54.4%, and 16.9% to 38.1% of patients with T2DM had well‐controlled glycemia, residual hyperglycemia, and uncontrolled hyperglycemia, respectively. In CTRs, respective ranges were 21.8% to 33.6%, 31.5% to 35.6%, and 30.7% to 46.8%, and in EMR databases were 4.4% to 21.0%, 23.9% to 31.8%, and 53.6% to 63.8%. Significant predictor factors of residual hyperglycemia identified from RCT data included high baseline HbA(1c) (all countries/regions except Brazil), high baseline FPG (United Kingdom/Japan), longer duration of diabetes (Brazil), and female sex (Europe/Latin America). CONCLUSIONS: Irrespective of intrinsic differences between data sources, 24% to 54% of patients with T2DM globally had residual hyperglycemia with HbA(1c) not at target, despite achieving FPG control, indicating a significant unmet need for postprandial glycemic control. |
format | Online Article Text |
id | pubmed-5347910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53479102017-03-23 A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin Raccah, Denis Chou, Engels Colagiuri, Stephen Gaàl, Zsolt Lavalle, Fernando Mkrtumyan, Ashot Nikonova, Elena Tentolouris, Nikolaos Vidal, Josep Davies, Melanie Diabetes Metab Res Rev Research Articles BACKGROUND: This study used data from different sources to identify the extent of the unmet need for postprandial glycemic control in patients with type 2 diabetes mellitus (T2DM) after the initiation of basal insulin therapy in Europe, Asia Pacific, the United States, and Latin America. METHODS: Different levels of evidence were used as available for each country/region, with data extracted from seven randomized controlled trials (RCTs), three clinical trial registries (CTRs), and three electronic medical record (EMR) databases. Glycemic status was categorized as “well controlled” (glycated hemoglobin [HbA(1c)] at target [<7%]), “residual hyperglycemia” (fasting plasma glucose [FPG] but not HbA(1c) at target [FPG <7.2/7.8 mmol/L, <130/140 mg/dL, depending on country‐specific recommendations]), or “uncontrolled” (both FPG and HbA(1c) above target). Predictor factors were identified from the RCT data set using logistic regression analysis. RESULTS: RCT data showed that 16.9% to 28.0%, 42.7% to 54.4%, and 16.9% to 38.1% of patients with T2DM had well‐controlled glycemia, residual hyperglycemia, and uncontrolled hyperglycemia, respectively. In CTRs, respective ranges were 21.8% to 33.6%, 31.5% to 35.6%, and 30.7% to 46.8%, and in EMR databases were 4.4% to 21.0%, 23.9% to 31.8%, and 53.6% to 63.8%. Significant predictor factors of residual hyperglycemia identified from RCT data included high baseline HbA(1c) (all countries/regions except Brazil), high baseline FPG (United Kingdom/Japan), longer duration of diabetes (Brazil), and female sex (Europe/Latin America). CONCLUSIONS: Irrespective of intrinsic differences between data sources, 24% to 54% of patients with T2DM globally had residual hyperglycemia with HbA(1c) not at target, despite achieving FPG control, indicating a significant unmet need for postprandial glycemic control. John Wiley and Sons Inc. 2016-10-13 2017-03 /pmc/articles/PMC5347910/ /pubmed/27606888 http://dx.doi.org/10.1002/dmrr.2858 Text en © 2016 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Raccah, Denis Chou, Engels Colagiuri, Stephen Gaàl, Zsolt Lavalle, Fernando Mkrtumyan, Ashot Nikonova, Elena Tentolouris, Nikolaos Vidal, Josep Davies, Melanie A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title_full | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title_fullStr | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title_full_unstemmed | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title_short | A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
title_sort | global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347910/ https://www.ncbi.nlm.nih.gov/pubmed/27606888 http://dx.doi.org/10.1002/dmrr.2858 |
work_keys_str_mv | AT raccahdenis aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT chouengels aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT colagiuristephen aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT gaalzsolt aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT lavallefernando aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT mkrtumyanashot aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT nikonovaelena aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT tentolourisnikolaos aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT vidaljosep aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT daviesmelanie aglobalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT raccahdenis globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT chouengels globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT colagiuristephen globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT gaalzsolt globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT lavallefernando globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT mkrtumyanashot globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT nikonovaelena globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT tentolourisnikolaos globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT vidaljosep globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin AT daviesmelanie globalstudyoftheunmetneedforglycemiccontrolandpredictorfactorsamongpatientswithtype2diabetesmellituswhohaveachievedoptimalfastingplasmaglucosecontrolonbasalinsulin |